Good comment. It’s a waiting game. The business is progressing very well by all accounts. Confirmation of the sales figures cannot be ignored by the market. What excites me is the quality of the recruits. They seem best in class in best in class companies.The ophthalmology business is a boutique one. The reps know their competition etc and when they leave one established company to join a minnow presently it augurs well. They see the future and their bonus size. I hope the August audited results might give us a figure on July sales to excited the SP.
- Forums
- ASX - By Stock
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
Good comment. It’s a waiting game. The business is progressing...
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.91M |
Open | High | Low | Value | Volume |
24.0¢ | 24.5¢ | 24.0¢ | $73.06K | 304.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 342553 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 50108 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 342553 | 0.235 |
2 | 93400 | 0.230 |
3 | 75000 | 0.225 |
8 | 239721 | 0.220 |
4 | 228594 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 50108 | 1 |
0.245 | 15000 | 1 |
0.250 | 100000 | 1 |
0.255 | 1768 | 1 |
0.265 | 70000 | 3 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |